Exhibit 107
CALCULATION OF FILING FEE TABLE
Form S-3
(Form Type)
Immunic, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Class Title (1) | Fee Calculation or Carry Forward Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit (1) | Maximum Aggregate Offering Price (1) | Fee Rate | Amount of Registration Fee (2) | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | ||||||||||||||||||
| Newly Registered Securities | |||||||||||||||||||||||||||||
| Fees to be Paid | Equity | Common Stock, par value $0.0001 per share | 457(o) | ||||||||||||||||||||||||||
| Fees to be Paid | Equity | Preferred Stock, par value $0.0001 per share | 457(o) | ||||||||||||||||||||||||||
| Fees to be Paid | Other | Warrants | 457(o) | ||||||||||||||||||||||||||
| Fees to be Paid | Other | Debt Securities (2) | 457(o) | ||||||||||||||||||||||||||
| Fees to be Paid | Other | Units(3) | 457(o) | ||||||||||||||||||||||||||
| Fees to be Paid | Unallocated (Universal) Shelf | Unallocated (Universal) Shelf | 457(o) | $ | 250,000,000 | (4) | 0.00014760 | $ | 36,900 | (4) | |||||||||||||||||||
| Fees Previously Paid | Unallocated (Universal) Shelf | Unallocated (Universal) Shelf | 457(o) | $ | 0 | (4) | 0.00014760 | $ | 0 | (4) | |||||||||||||||||||
| Carry Forward Securities | |||||||||||||||||||||||||||||
| Carry Forward Securities | Equity | Common Stock, par value $0.0001 per share | 415(a)(6) | S-3 | 333-250083 | November 24, 2020 | |||||||||||||||||||||||
| Carry Forward Securities | Equity | Preferred Stock, par value $0.0001 per share | 415(a)(6) | S-3 | 333-250083 | November 24, 2020 | |||||||||||||||||||||||
| Carry Forward Securities | Other | Warrants | 415(a)(6) | S-3 | 333-250083 | November 24, 2020 | |||||||||||||||||||||||
| Carry Forward Securities | Other | Debt Securities (2) | 415(a)(6) | ||||||||||||||||||||||||||
| Carry Forward Securities | Other | Units (3) | 415(a)(6) | S-3 | 333-250083 | November 24, 2020 | |||||||||||||||||||||||
| Carry Forward Securities | Unallocated (Universal) Shelf | Unallocated (Universal) Shelf | 415(a)(6) | $ | 163,100,000 | (4)(5) | S-3 | 333-250083 | November 24, 2020 | $ | 17,794.21 | (4) | |||||||||||||||||
| Total Offering Amounts | $ | 413,100,000 | $ | 54,694.21 | |||||||||||||||||||||||||
| Total Fees Previously Paid | $ | 17,794.21 | |||||||||||||||||||||||||||
| Total Fee Offsets | $ | 0 | |||||||||||||||||||||||||||
| Net Fee Due | $ | 36,900 | (4) | ||||||||||||||||||||||||||
| (1) | The aggregate maximum offering price of all securities issued or issuable by Immunic, Inc. (the “Registrant”) that are registered pursuant to this Registration Statement shall not exceed $250,000,000. The proposed maximum aggregate offering price is estimated solely for the purpose of computing the registration fee pursuant to Rule 457(o) under the Securities Act of 1933 (the “Securities Act”). For so long as the Registrant’s public float remains below $75,000,000, the Registrant will limit its issuance of securities in any twelve month calendar period to an aggregate market value (determined as of the time of issuance of that security) not in excess of one-third of the aggregate market value of all voting and non-voting common equity held by non-affiliates of the Registrant in compliance with General Instruction I.B.6 of Form S-3. |
| (2) | Calculated pursuant to Rule 457(o) under the Securities Act. The amount and price are exclusive of accrued interest, if any, on the debt securities. The amount to be registered and proposed maximum aggregate offering price are not specified as to each class of security pursuant to General Instruction II.D of Form S-3 under the Securities Act. |
| (3) | Units may consist of one or more shares of common stock, shares of preferred stock, debt securities, or warrants issued by the Registrant, or any combination thereof. |
| (4) | Pursuant to Rule 415(a)(6) under the Securities Act, the Registrant is registering hereby $163,100,000 of unsold securities (the “Unsold Securities”) previously registered under the Registrant’s prior registration statement on Form S-3 (File No. 333-250083), which was initially filed on November 13, 2020 (the “Prior Registration Statement”) and will expire on November 24. 2023. The registration fee of $17,794.21 relating to the Unsold Securities, which the Registrant previously paid, will continue to be applied to those Unsold Securities pursuant to Rule 415(a)(6). Pursuant to Rule 415(a)(6), the offering of such Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this Registration Statement. In addition to Unsold Securities being carried forward from the Prior Registration Statement, the Registrant is also registering hereby the offer and sale of an additional $250,000,000 of new securities for which the Registrant is paying a registration fee of $36,900. |
| (5) | Pursuant to Rule 415(a)(5) under the Securities Act, the Registrant may continue to offer and sell Unsold Securities under the Prior Registration Statement until the earlier of (i) the date on which this Registration Statement is declared effective by the Securities and Exchange Commission, and (ii) May 22, 2024, which is 180 days after the third-year anniversary of the effective date of the Prior Registration Statement (the “Expiration Date”). Pursuant to Rule 415(a)(6) under the Securities Act, if on or prior to the Expiration Date the Registrant sells Unsold Securities under the Prior Registration Statement, the Registrant shall file a pre-effective amendment to this Registration Statement to update the amount of Unsold Securities which are being registered under this Registration Statement, and upon effectiveness of this Registration Statement may continue to offer and sell such Unsold Securities under this Registration Statement. |
